Literature DB >> 10861471

PAX6 methylation and ectopic expression in human tumor cells.

C E Salem1, I D Markl, C M Bender, F A Gonzales, P A Jones, G Liang.   

Abstract

The mechanisms underlying the de novo methylation of CpG islands in human cancer remain almost completely unknown. We used a methylation-sensitive arbitrarily primed polymerase chain reaction (Ms AP-PCR) technique to scan genomic DNA for differential methylation patterns and identified a 550 bp band that was hypermethylated in a majority of colon and bladder cancer cells. This band corresponded to a CpG-rich region in exon 5 of PAX6, which is a highly conserved transcription regulatory factor involved in embryogenesis. Interestingly, exon 5 was very frequently methylated in solid tumors compared with adjacent normal tissues, 17 out of 27 (63%) in bladder, and colon, but the promoter remained unmethylated in all these cases. This methylation was not effective in blocking transcription since ectopic expression of PAX6 was seen in several tumors and cell lines with extensive exon 5 methylation. De novo methylation of the promoter was only seen in tumor cell lines and was associated with gene silencing since treatment with 5-aza-2'-deoxycytidine restored expression to the cells and resulted in a less methylated promoter. Thus, ectopic expression and hypermethylation of exon 5 of PAX6 demonstrate that methylation within a transcribed region, as opposed to promoter methylation, does not block gene expression. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861471     DOI: 10.1002/1097-0215(20000715)87:2<179::aid-ijc4>3.0.co;2-x

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  Hypermethylation in bladder cancer: biological pathways and translational applications.

Authors:  Marta Sánchez-Carbayo
Journal:  Tumour Biol       Date:  2012-01-25

2.  Gene expression levels in different stages of progression in oral squamous cell carcinoma.

Authors:  Winston Patrick Kuo; Tor-Kristian Jenssen; Peter J Park; Mark W Lingen; Rifat Hasina; Lucila Ohno-Machado
Journal:  Proc AMIA Symp       Date:  2002

3.  Gene body methylation can alter gene expression and is a therapeutic target in cancer.

Authors:  Xiaojing Yang; Han Han; Daniel D De Carvalho; Fides D Lay; Peter A Jones; Gangning Liang
Journal:  Cancer Cell       Date:  2014-09-25       Impact factor: 31.743

4.  Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: a phase I pilot study.

Authors:  Li-Shu Wang; Mark Arnold; Yi-Wen Huang; Christine Sardo; Claire Seguin; Edward Martin; Tim H-M Huang; Ken Riedl; Steven Schwartz; Wendy Frankel; Dennis Pearl; Yiqing Xu; John Winston; Guang-Yu Yang; Gary Stoner
Journal:  Clin Cancer Res       Date:  2010-12-01       Impact factor: 12.531

5.  Analysis of tissue-specific differentially methylated regions (TDMs) in humans.

Authors:  Eiko Kitamura; Jun Igarashi; Aiko Morohashi; Naoko Hida; Toshinori Oinuma; Norimichi Nemoto; Fei Song; Srimoyee Ghosh; William A Held; Chikako Yoshida-Noro; Hiroki Nagase
Journal:  Genomics       Date:  2006-12-26       Impact factor: 5.736

6.  Expression and epigenetic modulation of sonic hedgehog-GLI1 pathway genes in neuroblastoma cell lines and tumors.

Authors:  Mehdi H Shahi; Paula Schiapparelli; Mohammad Afzal; Subrata Sinha; Juan A Rey; Javier S Castresana
Journal:  Tumour Biol       Date:  2010-09-10

7.  Identification and analysis of an early diagnostic marker for malignant melanoma: ZAR1 intra-genic differential methylation.

Authors:  Yui Shinojima; Tadashi Terui; Hiroyuki Hara; Makoto Kimura; Jun Igarashi; Xiaofei Wang; Hiroyuki Kawashima; Yujin Kobayashi; Satomi Muroi; Satoshi Hayakawa; Mariko Esumi; Kyoko Fujiwara; Srimoyee Ghosh; Tatsuo Yamamoto; William Held; Hiroki Nagase
Journal:  J Dermatol Sci       Date:  2010-05-20       Impact factor: 4.563

8.  Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer.

Authors:  Xiangxian Zhang; Xiao Yang; Junling Wang; Tiansong Liang; Yue Gu; Daoke Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  PAX6 is expressed in pancreatic cancer and actively participates in cancer progression through activation of the MET tyrosine kinase receptor gene.

Authors:  Joseph B Mascarenhas; Kacey P Young; Erica L Littlejohn; Brian K Yoo; Ravi Salgia; Deborah Lang
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

Review 10.  Transcriptional and epigenetic mechanisms of early cortical development: An examination of how Pax6 coordinates cortical development.

Authors:  Athéna R Ypsilanti; John L R Rubenstein
Journal:  J Comp Neurol       Date:  2015-08-25       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.